Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer DiseaseEdmond Teng, Carlo de Lena, Siddhartha Lieten et al.|JAMA Neurology|2022Cited by 188
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s diseaseSandra Sanabria Bohórquez, Robby M. Weimer, Jan Mařı́k et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019Cited by 130
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathologyKaj Blennow, Kina Höglund, Chun Chen et al.|Brain|2019Cited by 106
Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer's diseaseEdmond Teng, Robby M. Weimer, Michael E. Ward et al.|Neurobiology of Aging|2019Cited by 46
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J. Bateman, Bruno Dubois, Yan Li et al.|The Lancet Neurology|2025Cited by 39